LEUKEMIA ACUTE MYELOID - AML
Clinical trials for LEUKEMIA ACUTE MYELOID - AML explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA ACUTE MYELOID - AML trials appear
Sign up with your email to follow new studies for LEUKEMIA ACUTE MYELOID - AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune booster aims to stop childhood cancer return after transplant
Disease control Not yet recruitingThis early-phase trial tests a new therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy uses specially designed immune cells to help the body's natural killer cells fight any remaining cancer. The main goal …
Matched conditions: LEUKEMIA ACUTE MYELOID - AML
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated May 17, 2026 21:18 UTC
-
New hope for AML patients: drug combo trial launches
Disease control Not yet recruitingThis early-phase trial tests adding tocilizumab to standard chemotherapy (venetoclax and azacitidine) for adults with acute myeloid leukemia who cannot undergo intensive treatment. The goal is to find the safest dose and see if the combination improves response. About 12 particip…
Matched conditions: LEUKEMIA ACUTE MYELOID - AML
Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC